Synapse - A phase II trial of peri-transplant palifermin with busulfan, melphalan and fludarabine followed by T-cell depleted hematopoietic stem cell transplants in patients with advanced myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) evolved from MDS

A phase II trial of peri-transplant palifermin with busulfan, melphalan and fludarabine followed by T-cell depleted hematopoietic stem cell transplants in patients with advanced myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) evolved from MDS Meeting Abstract

Authors:	Tamari, R.; Sheetal, S. R.; Kuk, D.; Papadopoulos, E. B.; Jakubowski, A. A.; Boulad, F.; Small, T. N.; Kernan, N. A.; Perales, M. A.; Koehne, G.; Ponce, D. M.; Devlin, S.; Goldberg, J. D.; Young, J. W.; Giralt, S. A.; O'Reilly, R. J.; Castro-Malaspina, H. R.
Abstract Title:	A phase II trial of peri-transplant palifermin with busulfan, melphalan and fludarabine followed by T-cell depleted hematopoietic stem cell transplants in patients with advanced myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) evolved from MDS
Meeting Title:	54th Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	120
Issue:	21
Meeting Dates:	2012 Dec 8-11
Meeting Location:	Atlanta, GA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2012-11-01
Language:	English
ACCESSION:	WOS:000313838903056
PROVIDER:	wos
DOI:	10.1182/blood.V120.21.1935.1935
Notes:	--- - Meeting Abstract: 1935 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos"